Global Low Molecular Weight Nucleic Acid Drugs Market Growth 2022-2028
The relatively low molecular weight nucleic acid drugs, such as miRNA, ASO, siRNA, aptamers, and ribozymes, could be classified as oligonucleotides that do not express proteins directly. Small Nucleic Acid Drugs utilize nucleic acid, which refer to substances such as DNA and RNA that control genetic information, as drugs. These allow targeting of molecules such as mRNA and miRNA that cannot be targeted with traditional low molecular weight drugs and antibody medicines, and there is a great expectation for these drugs as next generation pharmaceuticals. Active research is being conducted globally as it is expected to lead to the creation of drugs which were previously intractable.
The global market for Low Molecular Weight Nucleic Acid Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Low Molecular Weight Nucleic Acid Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Low Molecular Weight Nucleic Acid Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Low Molecular Weight Nucleic Acid Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Low Molecular Weight Nucleic Acid Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Low Molecular Weight Nucleic Acid Drugs players cover Novartis, Ionis, Nippon Shinyaku, Alnylam and Sarepta Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Low Molecular Weight Nucleic Acid Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Low Molecular Weight Nucleic Acid Drugs market, with both quantitative and qualitative data, to help readers understand how the Low Molecular Weight Nucleic Acid Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Low Molecular Weight Nucleic Acid Drugs market and forecasts the market size by Type (ASO, siRNA and Other), by Application (Cardiovascular Diseases, Hepatitis B, Hypertension and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
ASO
siRNA
Other
Segmentation by application
Cardiovascular Diseases
Hepatitis B
Hypertension
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novartis
Ionis
Nippon Shinyaku
Alnylam
Sarepta Therapeutics
MiNA Therapeutics
BioNTech
Moderna
Chapter Introduction
Chapter 1: Scope of Low Molecular Weight Nucleic Acid Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Low Molecular Weight Nucleic Acid Drugs market size (sales and revenue) and CAGR, Low Molecular Weight Nucleic Acid Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Low Molecular Weight Nucleic Acid Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Low Molecular Weight Nucleic Acid Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Low Molecular Weight Nucleic Acid Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Novartis, Ionis, Nippon Shinyaku, Alnylam, Sarepta Therapeutics, MiNA Therapeutics, BioNTech and Moderna, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Low Molecular Weight Nucleic Acid Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Low Molecular Weight Nucleic Acid Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Low Molecular Weight Nucleic Acid Drugs by Country/Region, 2017, 2022 & 2028
2.2 Low Molecular Weight Nucleic Acid Drugs Segment by Type
2.2.1 ASO
2.2.2 siRNA
2.2.3 Other
2.3 Low Molecular Weight Nucleic Acid Drugs Sales by Type
2.3.1 Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Low Molecular Weight Nucleic Acid Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Low Molecular Weight Nucleic Acid Drugs Sale Price by Type (2017-2022)
2.4 Low Molecular Weight Nucleic Acid Drugs Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Hepatitis B
2.4.3 Hypertension
2.4.4 Other
2.5 Low Molecular Weight Nucleic Acid Drugs Sales by Application
2.5.1 Global Low Molecular Weight Nucleic Acid Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Low Molecular Weight Nucleic Acid Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Low Molecular Weight Nucleic Acid Drugs Sale Price by Application (2017-2022)
3 Global Low Molecular Weight Nucleic Acid Drugs by Company
3.1 Global Low Molecular Weight Nucleic Acid Drugs Breakdown Data by Company
3.1.1 Global Low Molecular Weight Nucleic Acid Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Company (2020-2022)
3.2 Global Low Molecular Weight Nucleic Acid Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Low Molecular Weight Nucleic Acid Drugs Revenue by Company (2020-2022)
3.2.2 Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Low Molecular Weight Nucleic Acid Drugs Sale Price by Company
3.4 Key Manufacturers Low Molecular Weight Nucleic Acid Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Low Molecular Weight Nucleic Acid Drugs Product Location Distribution
3.4.2 Players Low Molecular Weight Nucleic Acid Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Low Molecular Weight Nucleic Acid Drugs by Geographic Region
4.1 World Historic Low Molecular Weight Nucleic Acid Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Low Molecular Weight Nucleic Acid Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Low Molecular Weight Nucleic Acid Drugs Annual Revenue by Geographic Region
4.2 World Historic Low Molecular Weight Nucleic Acid Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Low Molecular Weight Nucleic Acid Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Low Molecular Weight Nucleic Acid Drugs Annual Revenue by Country/Region
4.3 Americas Low Molecular Weight Nucleic Acid Drugs Sales Growth
4.4 APAC Low Molecular Weight Nucleic Acid Drugs Sales Growth
4.5 Europe Low Molecular Weight Nucleic Acid Drugs Sales Growth
4.6 Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales Growth
5 Americas
5.1 Americas Low Molecular Weight Nucleic Acid Drugs Sales by Country
5.1.1 Americas Low Molecular Weight Nucleic Acid Drugs Sales by Country (2017-2022)
5.1.2 Americas Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2017-2022)
5.2 Americas Low Molecular Weight Nucleic Acid Drugs Sales by Type
5.3 Americas Low Molecular Weight Nucleic Acid Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Low Molecular Weight Nucleic Acid Drugs Sales by Region
6.1.1 APAC Low Molecular Weight Nucleic Acid Drugs Sales by Region (2017-2022)
6.1.2 APAC Low Molecular Weight Nucleic Acid Drugs Revenue by Region (2017-2022)
6.2 APAC Low Molecular Weight Nucleic Acid Drugs Sales by Type
6.3 APAC Low Molecular Weight Nucleic Acid Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Low Molecular Weight Nucleic Acid Drugs by Country
7.1.1 Europe Low Molecular Weight Nucleic Acid Drugs Sales by Country (2017-2022)
7.1.2 Europe Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2017-2022)
7.2 Europe Low Molecular Weight Nucleic Acid Drugs Sales by Type
7.3 Europe Low Molecular Weight Nucleic Acid Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Low Molecular Weight Nucleic Acid Drugs by Country
8.1.1 Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales by Type
8.3 Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Low Molecular Weight Nucleic Acid Drugs
10.3 Manufacturing Process Analysis of Low Molecular Weight Nucleic Acid Drugs
10.4 Industry Chain Structure of Low Molecular Weight Nucleic Acid Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Low Molecular Weight Nucleic Acid Drugs Distributors
11.3 Low Molecular Weight Nucleic Acid Drugs Customer
12 World Forecast Review for Low Molecular Weight Nucleic Acid Drugs by Geographic Region
12.1 Global Low Molecular Weight Nucleic Acid Drugs Market Size Forecast by Region
12.1.1 Global Low Molecular Weight Nucleic Acid Drugs Forecast by Region (2023-2028)
12.1.2 Global Low Molecular Weight Nucleic Acid Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Low Molecular Weight Nucleic Acid Drugs Forecast by Type
12.7 Global Low Molecular Weight Nucleic Acid Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Low Molecular Weight Nucleic Acid Drugs Product Offered
13.1.3 Novartis Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Ionis
13.2.1 Ionis Company Information
13.2.2 Ionis Low Molecular Weight Nucleic Acid Drugs Product Offered
13.2.3 Ionis Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ionis Main Business Overview
13.2.5 Ionis Latest Developments
13.3 Nippon Shinyaku
13.3.1 Nippon Shinyaku Company Information
13.3.2 Nippon Shinyaku Low Molecular Weight Nucleic Acid Drugs Product Offered
13.3.3 Nippon Shinyaku Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nippon Shinyaku Main Business Overview
13.3.5 Nippon Shinyaku Latest Developments
13.4 Alnylam
13.4.1 Alnylam Company Information
13.4.2 Alnylam Low Molecular Weight Nucleic Acid Drugs Product Offered
13.4.3 Alnylam Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Alnylam Main Business Overview
13.4.5 Alnylam Latest Developments
13.5 Sarepta Therapeutics
13.5.1 Sarepta Therapeutics Company Information
13.5.2 Sarepta Therapeutics Low Molecular Weight Nucleic Acid Drugs Product Offered
13.5.3 Sarepta Therapeutics Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sarepta Therapeutics Main Business Overview
13.5.5 Sarepta Therapeutics Latest Developments
13.6 MiNA Therapeutics
13.6.1 MiNA Therapeutics Company Information
13.6.2 MiNA Therapeutics Low Molecular Weight Nucleic Acid Drugs Product Offered
13.6.3 MiNA Therapeutics Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 MiNA Therapeutics Main Business Overview
13.6.5 MiNA Therapeutics Latest Developments
13.7 BioNTech
13.7.1 BioNTech Company Information
13.7.2 BioNTech Low Molecular Weight Nucleic Acid Drugs Product Offered
13.7.3 BioNTech Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 BioNTech Main Business Overview
13.7.5 BioNTech Latest Developments
13.8 Moderna
13.8.1 Moderna Company Information
13.8.2 Moderna Low Molecular Weight Nucleic Acid Drugs Product Offered
13.8.3 Moderna Low Molecular Weight Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Moderna Main Business Overview
13.8.5 Moderna Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Low Molecular Weight Nucleic Acid Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Low Molecular Weight Nucleic Acid Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ASO
Table 4. Major Players of siRNA
Table 5. Major Players of Other
Table 6. Global Low Molecular Weight Nucleic Acid Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Low Molecular Weight Nucleic Acid Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Low Molecular Weight Nucleic Acid Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Application (2017-2022)
Table 14. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Low Molecular Weight Nucleic Acid Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Low Molecular Weight Nucleic Acid Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Low Molecular Weight Nucleic Acid Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Low Molecular Weight Nucleic Acid Drugs Producing Area Distribution and Sales Area
Table 22. Players Low Molecular Weight Nucleic Acid Drugs Products Offered
Table 23. Low Molecular Weight Nucleic Acid Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Low Molecular Weight Nucleic Acid Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Low Molecular Weight Nucleic Acid Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Low Molecular Weight Nucleic Acid Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Low Molecular Weight Nucleic Acid Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Low Molecular Weight Nucleic Acid Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Low Molecular Weight Nucleic Acid Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Low Molecular Weight Nucleic Acid Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Low Molecular Weight Nucleic Acid Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Low Molecular Weight Nucleic Acid Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Low Molecular Weight Nucleic Acid Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Low Molecular Weight Nucleic Acid Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Low Molecular Weight Nucleic Acid Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Low Molecular Weight Nucleic Acid Drugs
Table 67. Key Market Challenges & Risks of Low Molecular Weight Nucleic Acid Drugs
Table 68. Key Industry Trends of Low Molecular Weight Nucleic Acid Drugs
Table 69. Low Molecular Weight Nucleic Acid Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Low Molecular Weight Nucleic Acid Drugs Distributors List
Table 72. Low Molecular Weight Nucleic Acid Drugs Customer List
Table 73. Global Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Forecast by Region
Table 75. Global Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Low Molecular Weight Nucleic Acid Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Low Molecular Weight Nucleic Acid Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 95. Novartis Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Ionis Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Ionis Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 100. Ionis Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Ionis Main Business
Table 102. Ionis Latest Developments
Table 103. Nippon Shinyaku Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Nippon Shinyaku Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 105. Nippon Shinyaku Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Nippon Shinyaku Main Business
Table 107. Nippon Shinyaku Latest Developments
Table 108. Alnylam Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Alnylam Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 110. Alnylam Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Alnylam Main Business
Table 112. Alnylam Latest Developments
Table 113. Sarepta Therapeutics Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sarepta Therapeutics Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 115. Sarepta Therapeutics Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Sarepta Therapeutics Main Business
Table 117. Sarepta Therapeutics Latest Developments
Table 118. MiNA Therapeutics Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. MiNA Therapeutics Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 120. MiNA Therapeutics Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. MiNA Therapeutics Main Business
Table 122. MiNA Therapeutics Latest Developments
Table 123. BioNTech Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. BioNTech Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 125. BioNTech Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. BioNTech Main Business
Table 127. BioNTech Latest Developments
Table 128. Moderna Basic Information, Low Molecular Weight Nucleic Acid Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Moderna Low Molecular Weight Nucleic Acid Drugs Product Offered
Table 130. Moderna Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Moderna Main Business
Table 132. Moderna Latest Developments
List of Figures
Figure 1. Picture of Low Molecular Weight Nucleic Acid Drugs
Figure 2. Low Molecular Weight Nucleic Acid Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Low Molecular Weight Nucleic Acid Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Low Molecular Weight Nucleic Acid Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ASO
Figure 10. Product Picture of siRNA
Figure 11. Product Picture of Other
Figure 12. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type in 2021
Figure 13. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Low Molecular Weight Nucleic Acid Drugs Consumed in Cardiovascular Diseases
Figure 15. Global Low Molecular Weight Nucleic Acid Drugs Market: Cardiovascular Diseases (2017-2022) & (K Units)
Figure 16. Low Molecular Weight Nucleic Acid Drugs Consumed in Hepatitis B
Figure 17. Global Low Molecular Weight Nucleic Acid Drugs Market: Hepatitis B (2017-2022) & (K Units)
Figure 18. Low Molecular Weight Nucleic Acid Drugs Consumed in Hypertension
Figure 19. Global Low Molecular Weight Nucleic Acid Drugs Market: Hypertension (2017-2022) & (K Units)
Figure 20. Low Molecular Weight Nucleic Acid Drugs Consumed in Other
Figure 21. Global Low Molecular Weight Nucleic Acid Drugs Market: Other (2017-2022) & (K Units)
Figure 22. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2017-2022)
Figure 23. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Application in 2021
Figure 24. Low Molecular Weight Nucleic Acid Drugs Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Company in 2021
Figure 26. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Geographic Region in 2021
Figure 28. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Region (2017-2022)
Figure 29. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country/Region in 2021
Figure 30. Americas Low Molecular Weight Nucleic Acid Drugs Sales 2017-2022 (K Units)
Figure 31. Americas Low Molecular Weight Nucleic Acid Drugs Revenue 2017-2022 ($ Millions)
Figure 32. APAC Low Molecular Weight Nucleic Acid Drugs Sales 2017-2022 (K Units)
Figure 33. APAC Low Molecular Weight Nucleic Acid Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Europe Low Molecular Weight Nucleic Acid Drugs Sales 2017-2022 (K Units)
Figure 35. Europe Low Molecular Weight Nucleic Acid Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Revenue 2017-2022 ($ Millions)
Figure 38. Americas Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country in 2021
Figure 39. Americas Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country in 2021
Figure 40. United States Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Region in 2021
Figure 45. APAC Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Regions in 2021
Figure 46. China Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country in 2021
Figure 53. Europe Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country in 2021
Figure 54. Germany Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country in 2021
Figure 61. Egypt Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Low Molecular Weight Nucleic Acid Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Low Molecular Weight Nucleic Acid Drugs in 2021
Figure 67. Manufacturing Process Analysis of Low Molecular Weight Nucleic Acid Drugs
Figure 68. Industry Chain Structure of Low Molecular Weight Nucleic Acid Drugs
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets